A prospective study of adults scheduled for CAR T-cell therapy reported high completion rates using a digital neurocognitive monitoring prototype, but researchers flagged that the task metrics were not validated for neurotoxicity detection. The work assessed usability and adherence in a real clinical pathway, while noting limitations that prevent direct clinical interpretation. The findings suggest digital monitoring is feasible operationally, even as regulatory-grade endpoint validation remains a key gap.
Get the Daily Brief